Online citations, reference lists, and bibliographies.
← Back to Search

Rationale For The Use Of 5-HT1-like Agonists In The Treatment Of Migraine

W. Feniuk, P. Humphrey, M. Perren, H. Connor, E. Whalley
Published 2004 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
SummaryMigraine headache is thought to be associated with a dilatation of cranial blood vessels, particularly those in the dura mater, and an accompanying localized sterile inflammatory response. Sumatriptan is a highly selective 5-HT1-like receptor agonist which selectively constricts cranial blood vessels (including those in the dura mater). It also inhibits neurogenically-mediated plasma protein extravasation in the dura mater. Haemodynamic studies in anaesthetized animals have shown that sumatriptan selectively constricts the carotid arterial circulation and this effect appears to be restricted to an effect on carotid arteriovenous anastomoses. Sumatriptan has a much more selective pharmacological profile than ergot preparations which are also used in the acute treatment of migraine. The development of sumatriptan has been based on a vascular theory of migraine and its high degree of efficacy in the treatment of migraine strengthens the argument that dilatation of cranial blood vessels is the cause of vascular headache.
This paper references
10.1111/j.1476-5381.1989.tb11835.x
5‐HT1‐like receptors mediate 5‐hydroxytryptamine‐induced contraction of human isolated basilar artery
A. A. Parsons (1989)
10.1111/J.1468-2982.1989.TB00067.X
5-Hydroxytryptamine and its putative aetiological involvement in migraine
J. Lance (1989)
10.1177/03331024850050S376
Comparison of the Vasomotor Effects of the Calcium Entry Blockers Flunarizine and Nimodipine in Human Cerebral and Temporal Arteries
I. Jansen (1985)
10.1161/01.STR.21.4.555
Focal headache during balloon inflation in the internal carotid and middle cerebral arteries.
F. Nichols (1990)
10.1111/j.1468-2982.1989.tb00067.x
5-Hydroxytryptamine and its Putative Aetiological Involvement in Migraine
J. Lance (1989)
10.1111/j.1468-2982.1989.tb00069.x
The Pharmacology of the Novel 5-HT1-Like Receptor Agonist, GR43175
P. Humphrey (1989)
10.1113/jphysiol.1982.sp014427
Redistribution by 5‐hydroxytryptamine of carotid arterial blood at the expense of arteriovenous anastomotic blood flow
P. Saxena (1982)
10.1007/BF01642905
5-Hydroxytryptamine and the pathophysiology of migraine
P. Humphrey (2004)
The arteriovenous anastomoses and veins in migraine research
PR Saxena (1987)
10.1177/0333102489009S10193
Further Studies on the Mechanism of the Antimigraine Action of Sumatriptan
P. P. A. Humphrey (1989)
10.1111/j.1476-5381.1989.tb11787.x
The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs
W. Feniuk (1989)
10.1111/j.1476-5381.1989.tb11828.x
Characterization of 5‐HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5‐HT1‐like receptor agonist
H. Connor (1989)
10.1002/ANA.410160202
The neurobiology of vascular head pain
M. Moskowitz (1984)
10.1111/j.1468-2982.1989.tb00073.x
The Kinetics of 14C-GR43175 in Rat and Dog
F. Dallas (1989)
10.1111/j.1476-5381.1991.tb12173.x
Role of 5‐HT1‐like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan
Marinus O. Boer (1991)
10.1111/j.1476-5381.1985.tb08948.x
A comparison of 5‐hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists
W. Feniuk (1985)
A contribution to the mechanism of intracranial pain
W Penfield (1935)
10.1111/j.1476-5381.1980.tb10410.x
EVIDENCE FOR TWO TYPES OF EXCITATORY RECEPTOR FOR 5‐HYDROXYTRYPTAMINE IN DOG ISOLATED VASCULATURE
E. Apperley (1980)
10.1111/j.1476-5381.1988.tb11630.x
GR43175, a selective agonist for the 5‐HT1‐like receptor in dog isolated saphenous vein
P. Humphrey (1988)
10.1111/j.1476-5381.1991.tb12152.x
Vascular 5‐HT1‐like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5‐HT1A or 5‐HT1D subtype
M. Perren (1991)
10.1111/j.1476-5381.1989.tb11965.x
Reduction of cephalic arteriovenous shunting by ergotamine is not mediated by 5‐HT1‐like or 5‐HT2 receptors
A. H. Bom (1989)
10.1001/ARCHNEURPSYC.1938.02270040093005
MECHANISM OF MIGRAINE HEADACHE AND ACTION OF ERGOTAMINE TARTRATE
J. R. Graham (1938)
10.1016/0028-3908(86)90207-8
Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine
P. Bradley (1986)
10.1111/j.1468-2982.1989.tb00071.x
The Selective Closure of Feline Carotid Arteriovenous Anastomoses (AVAs) by GR43175
M. Perren (1989)
10.1111/j.1526-4610.1974.hed1304142.x
ROLE OF SOME BIOGENIC SUBSTANCES IN MIGRAINE AND RELEVANT MECHANISM IN ANTIMIGRAINE ACTION OF ERGOTAMINE‐STUDIES IN AN EXPERIMENTAL MODEL FOR MIGRAINE
Pramod R. Saxena (1974)
10.1111/J.1468-2982.1989.TB00071.X
The selective closure of feline carotid arteriovenous anastomoses (AVAs) by GR43175
M. Perren (1989)
10.1111/j.1526-4610.1989.hed2907420.x
Comparative Neuropharmacology of Dihydroergotamine and Sumatriptan (GR 43175)
B. G. McCarthy (1989)
10.1111/j.1476-5381.1990.tb14679.x
The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater
M. G. Buzzi (1990)
The arteriovenous anastomoses and veins in migraine research. In: Blau JN (ed) Migraine - therapeutic, conceptual and research aspects
PR Saxena (1987)
10.1161/01.RES.33.1.98
Responsiveness of Isolated Cerebral and Peripheral Arteries to Serotonin, Norepinephrine, and Transmural Electrical Stimulation
N. Toda (1973)
duction of cephalic arteriovenous shunting by ergotamine is not mediated by 5 - HTl - like or 5 - HT 2 receptors
AH Bom (1989)
Mechanisms of 5 - hydroxy - tryptamine - induced vasoconstriction
W Feniuk (1989)
10.1016/0922-4106(90)90190-9
The concept of selectivity in 5-HT receptor research.
I. van Wijngaarden (1990)
10.1111/J.1468-2982.1989.TB00075.X
Overview of initial clinical studies with intravenous and oral GR43175 in acute migraine
V. Perrin (1989)
10.1002/BJS.1800520105
New concepts on the aetiology and vascularization of meningiomata; the mechanisms of migraine; the chemical processes of the cerebrospinal fluid; and the formation of collections of blood or fluid in the subdural space
G. Rowbotham (1965)
[Pathogenesis of migraine].
H. KISTELSKA-NIELUBOWICZOWA (1953)
10.1001/ARCHSURG.1940.01210040002001
EXPERIMENTAL STUDIES ON HEADACHE: PAIN-SENSITIVE STRUCTURES OF THE HEAD AND THEIR SIGNIFICANCE IN HEADACHE
B. S. Ray (1940)
10.1007/BF01642901
Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions
M. Moskowitz (2004)
10.1007/BF00335317
The macro and microvasculature of the dura mater
C. Kerber (2004)
10.1016/0300-9629(90)90148-l
The Peripheral actions of 5-hydroxytryptamine
J. Fozard (1989)
10.1111/J.1468-2982.1989.TB00070.X
GR43175 does not share the complex pharmacology of the ergots
W. Feniuk (1989)
10.1111/j.1526-4610.1972.hed1202044.x
THE EFFECTS OF ANTIMIGRAINE DRUGS ON THE VASCULAR RESPONSES BY‐5‐HYDROXYTRYPTAMINE AND RELATED BIOGENIC SUBSTANCES ON THE EXTERNAL CAROTID BED OF DOGS: POSSIBLE PHARMACOLOGICAL IMPLICATIONS TO THEIR ANTIMIGRAINE ACTION
P. Saxena (1972)
10.1016/0014-2999(90)90529-F
Role of 5-HT2 receptors in serotonin-induced contraction in the human mammary artery.
A. Conti (1990)
10.1016/0014-2999(74)90206-4
Selective vasoconstriction in carotid vascular bed by methysergide: possible relevance to its antimigraine effect.
P. Saxena (1974)
10.1111/J.1526-4610.1967.HED0703134.X
The control of cranial arteries by humoral mechanisms and its relation to the migraine syndrome.
J. Lance (1967)



This paper is referenced by
10.1016/J.NEUROL.2014.07.010
La vasodilatation a-t-elle un rôle dans la migraine ? Non
Geneviève Demarquay (2014)
10.1007/s11940-014-0318-1
New Targets for Migraine Therapy
A. R. Tso (2014)
10.1177/0333102416638520
Genetic epidemiology of migraine and depression
Yuanhao Yang (2016)
10.1007/BF01642905
5-Hydroxytryptamine and the pathophysiology of migraine
P. Humphrey (2004)
10.1016/j.neuropharm.2004.03.006
Nitrergic and glutamatergic neuronal mechanisms at the trigeminovascular first-order synapse
G. Lambert (2004)
10.1517/14728214.8.2.437
Emerging drugs in migraine treatment
C. Waeber (2003)
10.1152/physrev.00034.2015
Pathophysiology of Migraine: A Disorder of Sensory Processing.
P. Goadsby (2017)
10.1007/S10870-009-9678-X
The Zolmitriptan-Pyridine (1:1) and Zolmitriptan-Propiophenone (3:2) Inclusion Complex
Sridhar Balasubramanian (2010)
10.1212/WNL.61.8_SUPPL_4.S9
Therapeutic implications of central and peripheral neurologic mechanisms in migraine
C. Waeber (2003)
10.1002/ana.20193
Activation of 5‐HT1B/1D receptor in the periaqueductal gray inhibits nociception
T. Bartsch (2004)
10.1517/14656566.2013.806487
Activation of 5-hydroxytryptamine1B/1D/1F receptors as a mechanism of action of antimigraine drugs
Martha B. Ramírez Rosas (2013)
10.1177/0333102418771350
Current understanding of meningeal and cerebral vascular function underlying migraine headache
D. Levy (2018)
10.2165/00044011-200626050-00006
Tanacetum parthenium and Salix alba (Mig-RL®) Combination in Migraine Prophylaxis
R. Shrivastava (2006)
10.1053/j.gastro.2008.06.085
Reversal of inflammatory and noninflammatory visceral pain by central or peripheral actions of sumatriptan.
L. Vera-Portocarrero (2008)
10.15255/kui.2018.027
Medicinal and pesticidal potentials of the constituents of the essential oil from Adenia cissampeloides leaves
M. Ogunlesi (2019)
10.1038/s41582-019-0216-y
Does inflammation have a role in migraine?
L. Edvinsson (2019)
10.1136/acupmed-2012-010195
The Combined Effect of Acupuncture and Tanacetum parthenium on quality of life in women with headache: Randomised study
Eliane Cristina Ferro (2012)
10.1007/978-1-60761-880-5_7
Animal Models of Central Neuropathic Pain
B. Hains (2011)
Calcitonin Gene-Related Peptide and Migraine: Implications for Therapy
U. Arulmani (2004)
10.1007/BF00168556
[3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study
C. Waeber (2004)
10.1111/j.1526-4610.2012.02124.x
Dihydroergotamine, Ergotamine, Methysergide and Sumatriptan – Basic Science in Relation to Migraine Treatment
C. Dahlöf (2012)
10.1007/BF03007109
L'influence des hormones gonadales sur la douleur
T. Dao (2003)
10.1097/SPC.0000000000000044
Serotonin, 5HT1 agonists, and migraine: new data, but old questions still not answered
G. Dussor (2014)
Cardiac and carotid vascular effects of 5-hydroxyttyptamine-related drugs in the pig
C. Villalón (1991)
Semantic Scholar Logo Some data provided by SemanticScholar